Asuragen Diagnostics Publication
AMP 2009 Posters
KRAS
TT15: Signature KRAS Mutations: A Single-Tube Assay for the Rapid Multiplex Detection
of KRAS Mutations in Codons 12 and 13.
Fei Ye, Zhe Yang, Walairat Laosinchai-Wolf, Paul Lebourgeois, and
Emmanuel Labourier
FMR1
G11: A Rapid PCR Method for the Determination of FMR1 Methylation Status in both
Males and Females.
Gary J. Latham1, Wenting Zhang2, Andrew Hadd1,
Paul J. Hagerman2,3, Timothy T. Stenzel1, Flora Tassone2,3
and Liangjing Chen1
1Asuragen Inc., Austin, Texas; 2Department of Biochemistry
and Molecular Medicine, University of California, School of Medicine, Davis, California;
3M.I.N.D. Institute, University of California Davis Medical Center, Sacramento,
California
G10: Two Novel PCR Strategies that Amplify and Accurately Report the Full Range
of FMR1 Genotypes without the need for Southern Blot.
Andrew Hadd1, Flora Tassone2,3, Stela Filipovic-Sadic1,
Liangjing Chen1, Jon Kempannien1, Wenting Zhang2,
Paul J. Hagerman2,3, Timothy Stenzel1, Gary J. Latham1
1Asuragen Inc., Austin, Texas; 2 University of California,
School of Medicine, Davis, California; 3M.I.N.D. Institute, University
of California Davis Medical Center, Sacramento, California
BCR/ABL1 Quant®
H21: Evaluation of BCR/ABL1 Quant Assay (RUO)* for the Quantitative Detection of
e1a2, b2a2, and b3a2 Fusion Transcripts.
Frank Buccini1, Walairat Laosinchai-Wolf2,
Justin Brown2, Emmanuel Labourier2, Elizabeth Fuentes1,
and James Weisberger1
1Bio-Reference Laboratories Inc, Elmwood Park, New Jersey; 2Asuragen
Inc., Austin, Texas
H12: Development of Armored RNA Quant® Reference Materials for the Standardization
of Quantitative BCR/ABL1 Testing.
Emmanuel Labourier, Frank Hui, Walairat Laosinchai-Wolf, Justin
Brown, Timothy Stenzel, and John Hedges
microRNAs
ST30: MicroRNA Biomarkers For Coloretal Cancer Diagnosis and Recurrence.
Tiffany Sanford, Martina Doleshal, Laura Langfield, Bhavna Choudhury,
Paul LeBourgeois, Timothy Stenzel, Alex Adai and Elizabeth Mambo
ST25: Evaluation of miRNA Signatures For Identification of Pancreatic Ductal Adenocarcinoma
in FFPE Specimens.
A.E. (Szafranska) Schwarzbach1, A. Adai1,
M. Lloyd1, T. Sanford1, M. Doleshal1, S. Hahn2,
G.J. Tsongalis3, G. Rateb4, C. Menard4, J.-A. Morisset4,
B. Andruss1 and T. Stenzel1
1Asuragen Inc., Austin, TX, USA; 2Department of Pathology
and Internal Medicine, Rühr University, Bochum, Germany; 3Department
of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA; 4Department
of Gastroenterology, University of Sherbrooke, Fleurimont, QC, Canada
RNA
TT40: Development of a cGMP-manufactured, streamlined RNA amplification, labeling,
and purification kit for microarray expression analysis optimized for the workflow
of the clinical molecular laboratory.
Justin Brown, Deepa Eveleigh, Colton Wilson, Melanie Palmer
Size Fractionation of BCR/ABL1 Quant (RUO)* PCR Products by Capillary Electrophoresis
to Determine e1a2, b2a2, and b3a2 Fusion Transcripts Identity
BCR/ABL1 Quant Web Note
Armored
Technology as a Solution for Calibration and Interlaboratory Standards in Leukemia
Minimal Residual Disease Monitoring
Walairat Laosinchai-Wolf, Vesselina Ivanova, Justin T Brown
Liquid
Bead Array Analysis as A Rapid Tool for Simultaneous Detection of Common Translocations
in AML, APL, ALL and CML Leukemias
Fei Ye, Walairat Laosinchai-Wolf, Cora Lahey, Mari Annguiano, Nathan Anderson, Andrew
Hadd, Jeff Williams
For other Asuragen's publications
click here